IL38087A - Preparation of n-(diethylaminoethyl)-2-methoxy-4-afilter for use in the filtration of blood mino-5-chloro-benzamide - Google Patents
Preparation of n-(diethylaminoethyl)-2-methoxy-4-afilter for use in the filtration of blood mino-5-chloro-benzamideInfo
- Publication number
- IL38087A IL38087A IL3808771A IL3808771A IL38087A IL 38087 A IL38087 A IL 38087A IL 3808771 A IL3808771 A IL 3808771A IL 3808771 A IL3808771 A IL 3808771A IL 38087 A IL38087 A IL 38087A
- Authority
- IL
- Israel
- Prior art keywords
- accordance
- disposable filter
- filter element
- blood
- filter
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 title claims description 42
- 239000008280 blood Substances 0.000 title claims description 42
- 238000001914 filtration Methods 0.000 title description 8
- 238000002360 preparation method Methods 0.000 title 1
- 229920000728 polyester Polymers 0.000 claims description 21
- 239000011148 porous material Substances 0.000 claims description 20
- 239000004033 plastic Substances 0.000 claims description 15
- 229920003023 plastic Polymers 0.000 claims description 15
- 230000017531 blood circulation Effects 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 4
- 230000004888 barrier function Effects 0.000 claims description 3
- 239000012503 blood component Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 description 14
- -1 alkylene glycols Chemical class 0.000 description 13
- 230000002612 cardiopulmonary effect Effects 0.000 description 12
- 239000004743 Polypropylene Substances 0.000 description 6
- 229920001155 polypropylene Polymers 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 229920004934 Dacron® Polymers 0.000 description 3
- 230000003727 cerebral blood flow Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000037323 metabolic rate Effects 0.000 description 3
- 210000002445 nipple Anatomy 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical class OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 1
- MEUAVGJWGDPTLF-UHFFFAOYSA-N 4-(5-benzenesulfonylamino-1-methyl-1h-benzoimidazol-2-ylmethyl)-benzamidine Chemical compound N=1C2=CC(NS(=O)(=O)C=3C=CC=CC=3)=CC=C2N(C)C=1CC1=CC=C(C(N)=N)C=C1 MEUAVGJWGDPTLF-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 229920004459 Kel-F® PCTFE Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001279 adipic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- UUAGAQFQZIEFAH-UHFFFAOYSA-N chlorotrifluoroethylene Chemical compound FC(F)=C(F)Cl UUAGAQFQZIEFAH-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- FYIBGDKNYYMMAG-UHFFFAOYSA-N ethane-1,2-diol;terephthalic acid Chemical compound OCCO.OC(=O)C1=CC=C(C(O)=O)C=C1 FYIBGDKNYYMMAG-UHFFFAOYSA-N 0.000 description 1
- 229920006379 extruded polypropylene Polymers 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003442 suberic acids Chemical class 0.000 description 1
- 150000003504 terephthalic acids Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Description
en fuoa mat? '- χ^ oa
FILTER FOR USE IN THE FILTRATION OF
BLOOD .
FILTER FOR USE IN THE FILTRATION OF BLOOD
ABSTRACT OF THE DISCLOSURE
A filter element is provided for use in the filtration of blood such as in cardiopulmonary bypass techniques in open heart surgery, comprising a woven square weave mesh of polyester monofilaments having a pore size within the range from about 25 to about 50 microns.
SPECIFICATION
Two kinds of filters have been in use for the filtration
of human blood. H owever, neither of these filters has been
capable of meeting the requirements for use in human blood
circulation systems,1 such as, for example, in cardiopulmonary
bypass and massive transfusion systems, used in open heart
surgery and similarj operations . Such systems require the
circulation of humah blood (not merely a single flow -through, as
in a bag blood transfusion, from storage to patient) at a high
flow rate . It is also important that the filter pass the blood without
The blood filters in use therefore have had a rather
I ' ' """"" "" ■ -~ ■ ' ■· ■' ·- · large pore size, to avoid early blockage and blood damage . The blood filters have been of two types, one having a pore size within the range from about 125 to about 140 microns, of open metal or plastic filament mesh, and the other having a pore size ranging up to several hundred microns, and of nonwoven plastic filament, especially Dacron wool, mat, made up of a plurality nf fine
monofilaments .
Lager U . S . patent No. 2, 473, 153, patented June 14, 1949 , shows a conventional elongated sack, pocket, or tube of woven material, having a closed top and an open, bottom neck (column 3 , lines 50 to 63), which is placed in the line of flow from a blood container.
Puschelberg et al. U . S . patent No. 2, 571, 059, patented October 9, 1951, show a similar filter made of phenolic resin-impregnated fabric, and which has at least 5600 openings per
square inch (column 3, lines 9 to 12, and 35 to 40). In order to have this many openings per square inch, taking into account the size of the monofilaments, which size in fact determines the size of the openings between them, the Puschelberg et al. strainer clearly has to have large pore openings in the 125 to 140 micron range .
Naftulin et al. U . S. patent No. 2, 914, 181, patented
November 24, 1959, show a nylon filter tube, also of open mesh (column 2, line 59), and Barr et al. U . S . patent No. 3, 557, 786, patented January 26, 1971 show a filter sheet woven from monofilament nylon (column 2, line 3) . Only Puschelberg et al. give
sufficient information to enable one to determine pore size, but/is apparent that the blood strainer assemblies shown in these references are of the conventional type, rather open, rather coarse, blood strainers, and that the blood filters therein are also of the
conventional type .
Such open mesh strainers were universally used in the blood filter art because it was known that less open fillers had a tendency to block rather quickly, after which flow was cut off , because of the removal of blood elements from the blood, blocking the pores of the filter . It was therefore considered that a filter having finer pores could not be used, and such filters were not used .
The other type of filter that has only recently come into use is the Dacron wool mat described by Swank British No . 1, 148, 744, published April 16, 1969, U. S . patent, No. 3, 448, 041, patented
June 3, 1969. The Swank filter is being marketed in the U . S . A .
under the trademark SWANK by Pioneer Filters, Inc . , of Oregon .
Although the Swank filter has a pore diameter of the same order of magnitude of the blood strainers, i. e . , several hundred microns, it has a tendency to remove far more blood material .
Swank explains his objective at column 3, starting at line 51 of his patent: to provide a finely divided material of high surface area so that it will selectively collect the adhesive storage -altered components of the blood, such a platelets and leucocytes .
The pore size is large enough so that the remaining nonadhesive
components can pass through the filter . The mat is not supposed to pack or to compress in use .
As a practical matter, this filter does not quite function in this way. Two groups of workers in this field, Egeblad et al .
Journal of Thoracic and Cardio-Vascular Surgery, Vol . 63,
No. 3, March 1972, pp. 384-390 and McNamara et al . , in a paper entitled "The Effective Filtration of Banked Blood", ound that the Swank filter removes very large quantities of blood components, including the desirable platelets and white bl ood cells, which should not be removed because they are necessary both to aid resistance to internal bleeding from the wound surface, and to promote
healing and combat infection. Besides that, because of the high proportion of materials removed, the Swank filter was f ound to block rather quickly in blood, circulation systems . Egeblad et al. found in fact that it could block within ten minutes of the time blood circulation began, requiring the use of a bypass line, with a second filter in reserve, in order to maintain flo .
These were the two kinds of filters available at the time that Dr . Patterson and Dr . Twichell began their investigations .
Patterson and Kessler, The Annals of Thoracic Surgery, Volume 9, Number 3, March, 1970, pages 221 to 228, Surgery,
Gynecology & Obstetrics, September, 1969, Volume 129, pages 505 to 510, reported the results of a number of experiments studying the effect of oxygenators on the blood during cardiopulmonary bypass . Patterson and Kessler pointed out that although cardiopulmonary bypass has proved a remarkable therapeutic tool, the most commonly used oxygenators in some way altered blood, which eventually
results in damage to the perfused tissue . The identity of the toxic material was not clear, but there was evidence that particulate matter was responsible, principally microemboli of silicone, gas, aggregated blood elements, and denatured lipoprotein.
Utilizing ultrasound techniques in a specially designed detection chamber, Patterson and Kessler showed that blood oxygenators produced microemboli in large quantities, and more over, they noted that the proportion in which the oxygen and the blood were mixed bore an impressive relationship to the formation of microemboli. The filters used in this work did not successfully remove large numbers
of microemboli from the blood, however,- as compared with a
canine lung which was used as a filter.
This work led Patterson, Brennan and Kessler to
correlate the microemboli with the significant depression in brain metabolism found after cardiopulmonary bypass. In experiments carried out on laboratory dogs, on partial cardiopulmonary bypass, with baseline studies of cerebral blood flow and cerebral metabolic rates for oxygen, glucose, C02 and lactate, they determined that particle (microemboli) counts when the animals were undergoing cardiopulmonary bypass averaged 8000 per minute. Average values for cerebral blood flow fell 25%, cerebral metabolic rates for oxygen fell 45%, C02 production by brain dropped 50%, and glucose metabolism fell 6%, and these changes were not immediately reversible. Then, these workers placed a filter in the arterial line, after which
particle counts averaged only 240 per minute, and there was no fall in cerebral blood flow; in fact, there was a slight increase.
A similar increase was noted in the flow in control animals connected to the pump oxygenator only momentarily, and then disconnected imm ediately. Moreover, with the filter in the circuit, cerebral metabolic rates for oxygen and glucose fell by only 9% and 16%, respectively, and returned to normal 1 1/2 hours later.
The filter employed in these studies was a disk of
stainless steel mesh, 6 inches in diameter, with a uniform pore size of 25 microns. However, this filter although suitable for dogs could not pass blood at the flow rates required for adult humans without severe hemolysis, because of its relatively low surface area, as Patterson and Twichell have reported in an as yet unpublished
report. For adult humans, high rates of blood flow are necessary if trauma is to be avoided. Moreover, a stainless steel filter is not practical for human blood use, since it is too costly to be disposable after use, and is too difficult and time consuming to clean to be reusable.
In accordance with the invention, a filter element is provided that is capable of passing human blood at a sufficiently
high flow rate to be useful in cardiopulmonary bypass and massive blood transfusion, and which at the same time, since it is made of an inexpensive plastic material, is disposable, and can be discarded after use. The plastic material employed is inert to blood, and the pore size of the filter element is fixed, so that it does not change in use or with temperature, in part because of the nature of the plastic filamentary material, and in part because of the manner in which the filaments are fixed against relative displacement in the element.
The filter element in accordance with the invention
comprises a woven square weave plastic mesh sheet of polyester monofilaments having a pore size within the range from about 25 to
about 50 microns, and an open area within the range from about 25% to about 40%. The filaments are locked in place at their crossing points. The diam eter of the monofilaments is important in determining both pore size and percent open area, the latter being important in maintaining a high blood flow rate through the filter. The monofilaments have a diameter within the range from about 25 to about 50 microns.
As used herein, "filter sheet" refers to the filtering sheet in a filter element. The term "filter element" refers to a filter sheet arranged in a structure that ensures fluid flow through the filter sheet when the element is placed in a housing across the line of flow from the inlet to the outlet. The term "filter unit" refers to the filter element plus a housing equipped at least with an inlet and an outlet.
Most polyester monofilaments available today are polyesters of ethylene glycol and terephthalic acid, which are available under the trademark Dacron. Polyester monofilaments can also be made of other polymers of alkylene glycols and dicarboxylic acids, usually, aromatic acids, but also cycloaliphatic and aliphatic acids, of which propylene glycol-1, 2, butylene glycol-2, 3 and 1, 2, and pentylene glycol-1, 2, -2, 3, and -1, 3, esterified with terephthalic acid or alkyl-substituted terephthalic acids, or adipic, or suberic acids, or cyclo-hexane-1, 4 dicarboxylic acid, are exemplary. The ethylene glycol -terephthalic acid polyester monofilaments are preferred, because of their availability and low cost. However, polyesters of other glycols and acids can be used.
Exemplary polyester monofilament screen cloths which can be employed as filter elements in accordance with the invention are made from polyester monofilament 40 microns in diameter with a mesh opening of 53 microns and 33 % open area, a mesh opening of 44 microns with 27% open area, and a mesh opening of 37 microns with 23% open area.
The monofilaments are locked in position at their points of crossing. The locking not only increases strength and .ri gi di ty
but it also fixes the pores against change in dimensions in use, which is extremely ■· important. If the pores are too small, below about
μ , they remove valuable blood components such as blood cells, which is of course undesirable. On the other hand, if they are too large, they permit microemboli to pass, which it is the purpose
of the filter to prevent.
Such filter sheets can be fitted into disposable filter elements of any design and configuration. For maximum open
area and high flow rate in a confined space, the filter sheet is preferably corrugated or convoluted, to provide a high surface area to flow. A suitable configuration of filter element has the filter sheet folded into a corrugated cylinder, the open ends of which are closed off by end caps, limiting access to the filtrate flow line to flow through the filter, the filtrate flow line being in operative connection to at least one of the end caps.
The end caps are also preferably of plastic material, and can be of polyester resin. The end caps can be bonded to the filter sheet, using a potting compound or an adhesive of conventional type. However, to ensure a bacteria-tight seal, it is preferred to fuse the end caps to the filte sheet, and for this purpose, a poly olefin such as polyethylene or polypropylene is preferred. Other plastic materials that can be used as the end caps include polyamides, polyvinyl chloride, polyvinylidene chloride, polycarbonates, as well
-ϊ
as Teflon, polytetrafluoroethylene and Kel-F, polytrifluorochloroethylene, but these are more difficult to bond.
To assist the filter sheet in retaining its shape, particularly a corrugated shape, it is preferable to provide a porous
support externally of the filter sheet, and preferably in close
juxtaposition to or in contact with the filter sheet on both the upstream side and the downstream side. The support material is stiff er than the filter sheet, and is preferably flexible, and also preferably plastic, so that it may be bonded to the same end cap in the filter element.
A preferred supporting material is Vexar mesh (extruded polypropylene netting) . Any perforated sheet having an uneven surface, such as dimpled, r idged, or quilted, can be used. Exemplary are polypropylene sheet, polyethylene sheet, poly viny lid ene chloride sheet, polyvinyl chloride sheet, and other plastic materials of the type conventionally used for end caps can be employed, with such an uneven surface, so as to provide drainage and prevent blocking of the filter sheet by the support sheet.
Preferred embodiments of the invention are illustrated in the drawings, in which:
Figure 1 represents an enlarged top view of a polyester monofilament mesh filter sheet in accordance with the invention;
Figure 2 represents an isometric view of a filter element embodying the filter sheet of Figure 1;
Figure^' represents a longitudinal section through a filter unit embodying a filter element of Figure 2.
Figure 3 represents a cross -sectional view taken along the lines 3 — 3 of Figure 2 and looking in the direction of the arrows;
Figure 5 represents an isometric view of anothe
embodiment of filter element in accordance with the invention;
Figure 6 represents a longitudinal section of the
filter element of Figure 5, taken along the lines ' 6-6 and looking in the direction of the arrows; and
Figure 7 represents a cross section of the filter element of Figure 5, taken along the lines 7-7, and looking in the direction of the arrows.
The filter sheet shown in Figure 1 is a sinter -bonded polyester monofilament square weave mesh, having a pore opening of 40μ , a monofila ent diameter of 40 μ , and 27% open area.
The weft monofilaments 1 are bonded to the warp monofilaments 2 at their points of crossing 3, defining fixed 40 μ pores 4, at their interstices. .
The filter element 5 shown in Figures 2 to 4 has such a filter sheet 6 in corrugated form, folded into a cylinder whose open ends are closed off by end caps 7, 8 of polypropylene. The end cap 7 has a central aperture 9, and an integral projecting annular connection 10 leading directly to an outlet of a filter unit housing. Externally and internally of the filter sheet corrugated protective supporting sheets 11, 12 of Vexar polypropylene netting, 50 mesh, and concentric to this corrugated three-sheet composite is a rigid perforated polypropylene core 14. The end caps are fused to the filter , sheet 6 and the Vexar sheets 11, 12.
The filter unit shown in Figures 3 and 4 comprises a filter housing 15 made in two portions 16, 17, bonded together by fusing at their mating portions 18, 19. Each housing portion 16, 1
has a line connection 20, 21 integral therewith, to accomplish an inline connection in a blood circulation system, such as in a cardiopulmonary bypass blood circulation system, or in a transfusion system . The
line connections shown are for 3/8 inch internal diameter tubing 27 .
The housing portions are made of plastic, such as polypropylene.
The line connection 20 in the embodiment shown serves as an inlet, and the line connection 21 as an outlet, but fluid flow can also be
in the opposite direction, if desired, without making any change in
the structure shown.
The filter element 5 is attached at the end cap 7-end to the housing wall at joint 28 via annular connection 10, which fits
snugly into the joint, and is bonded thereto. There is thus a
direct connection that is leak -tight and bacteria-tight, between the interior 26 of the filter element 5 and the line 27 attached to the
line connection 21 via a clamp 39.
The line connection 20 has an inwardly extending curved barrier 29 that continues to and abuts a recess 40 in end cap 8,
and extends over a segment of a circle at the portion of the housing
16 adjacent the vent 30, and serves to direct flow from the inlet
passage 31 away from the vent. This aids in venting gas such as air from the filter unit when it is first put onstream, without interference from incoming fluid flow .
The vent 30 is formed at a recess 32 in the housing
portion 16 in an outwardly extending nipple 33 with a through tapered bore 34. The end tip of the nipple 33 has four outwardly -extending lugs or projections 36, which are arranged to engage the internal
double threads 37 of the removable cap 38. The cap has a tapered
plug 39 which seats in bore 34j the tapers of plug ,39 and bore 34 being the same, and seals off the vent thereby in a leak-tight and bacteria-tight seal.
It will be apparent that this is a simple filter unit, easily fabricated from plastic by extrusion or compression molding or by casting in two housing parts, one cap, and one filter element, and that all parts are permanently bonded together. The unit is
thus susceptible to mass production at low cost to easily reproduced standard specifications, and can be discarded after use. Its small capacity, less than 500 cc, and preferably less tha 250 cc, suits it especially for any type of blood circulation system .
If desired, the line connections 20, 21 can be fitted with Luer locks, to facilitate connection to standard fittings of other types of medical equipment. The vent nipple 33 as shown has a
Luer lock fitting, for a standard Luer lock cap.
The filter element 50 of Figures 5 to 7 has a three-layer composite filter sheet 6 and support sheets 11, 12, in corrugated shingled form, with the corrugated folds 51 lying in the plane of the filter element in overlapping fashion. The composite is heat-sealed at 52 along its four sides, (or along three sides, if folded on itself) . The element has a line connection via the tube 53 extending into the open interior 54 of the element and terminating in a caged tip 55. The only access to and from the tube is via the filter sheet 6. The tube 53 can serve as an outlet tube for filtrate flow, in normal use, but it can also serve as an inlet in which case flow through the filter sheet 6 is in the opposite direction. This type of filter element is especially useful in a flexible ba -type of filter unit, in which the tube 53 can
extend to outside the bag 56 (shown in dashed lines in Figure 5), and can be heat-sealed to the bag in the sam e manner as to the filter
element. The other end of the bag has an inlet (or outlet) tube 57, for access to the other side of the filter element.
This type of filter element is especially useful for
blood filtration in which case it can be built into a standard blood
bag, but it can also have other uses, and any type of filter sheet
can be used, as well as any type of housing.
The corrugated configuration of the filter sheet in this element provides high surface area, and the shingled arrangement
of the corrugations make it possible to provide a flat pouch without the need for a core support, because the spaces between the shingles act as conduits, while at the same time, the shingled overlapping
structure provides structural support. The outer support layers of the three-layer composite are of heat-softenable material, while
the filter sheet is not affected under the conditions at which the
outer layers soften, so that the latter can be fused together in a
leak -tight heat seal through the filter sheet pores without ie'teioois ly affecting the filter sheet. The heat sear is easily effected by high frequency heating, and all heat seals can be formed simultaneously, including the heat seals with the tube.
Remarkable results have been obtained using filter elements in accordance with the invention, in a filter unit of a structure similar to that shown in Figures 3 to 4 in cardiopulmonary bypass. The following Examples illustrate such use, using a filter unit 6 x 9 cm . in outside dimensions, in a filter unit whose fluid volume was 240 cc , made entirely of polypropylene except for the polyester monofilament square weave mesh filter element.
The unit was tested in a cardiopulmonary bypass circuit in which one head of a double-headed roller pump recirculated blood through approximately 300 cm . of 3/8 inch plastic tubing, and a cardiotomy suction reservoir elevated 78 cm . above the pump.
Blood pressure was monitored before and after the filter. The second pump head was used to propel blood around a circuit which was similar except that it did not contain a filter. Each circuit was primed with 750 cc. of banked human blood. The perfusions were continued for four hours, at a flow rate of 4 liters per minute. Samples of blood were taken periodically for hematocrit, plasma hemoglobin, plasma electrophoresis, plasma lipoprotein electrophoresis, cholesterol, and platelets. The pressure drop across the filter was measured during the course of the perfusion, and also at the end of the perfusion, at which time the rate of flow was varied from 0 to 6 liters per minute. In three trials, the increase of plasma hemoglobin in the perfusate over four hours at a flow rate of 4 liters per minute was approximately the same, whether or not the filter was employed, showing that the filter had little adverse
effect. The platelet concentration at the end of the experiments was reduced 42 to 66% in the circuit with the filter and 46 to 60% in the one without, again showing that the filter had little adverse effect.
During the course of the four hours of perfusion at
4 liters per minute, the pressure drop across the filter ranged
between 8 and 40 mm . of mercury in five separate trials . Total plasma protein decreased by a mean of 10% in the circuit without the filter, and 11% in the circuit with the filter. The protein
fractions decreased 4 to 19%, in an inconsistent pattern. Plasma cholesterol decreased by a mean of 5%, if the filter was excluded, and by 13% when the filter was present.
The filter has been used during cardiopulmonary bypass in a series of tests on a small group of patients undergoing cardiac open heart surgery and has performed satisfactory. None of the patients has shown any evidence of cerebral damage.
16
Claims (18)
1. In a disposable filter element capable of passing ' human blood substantially without removal of normal and desirable blood components at a high flow rate and useful in human blood circulation systems to remove microemboli, having a filter sheet and means for directing blood to pass through the sheet interposed in the line of blood flow, the improvement which comprises as the filter a woven square weave plastic m esh of polyester monofilaments having a pore size within the range from about 25 to about 50 microns, and an open area within the range from about 25% to about 40%, the filaments being locked in place at their crossing points .
2. A disposable filter element in accordance with claim 1, in which the monofilaments have a diameter within the range from about 25 to about 50 microns .
3. A disposable filter element i accordance with claim 1, in which the polyester monofilaments are a polyester of ethylene glycol and terephthalic acid.
4. A disposable filter element in accordance with claim 1, in which the polyester monofilament mesh is composed of polyester monofilaments 40 microns in diameter with a mesh opening of 53 microns and 33% open area.
5. A disposable filter element in accordance with claim 1, in which the polyester monofilament mesh is composed of polyester monofilaments 40 microns in diameter with a mesh opening of 44 microns and 27% open area. 38087/2 A
6. A disposable filter element in accordance with claim 1, in which the polyester monofilament mesh is composed of polyester monofilaments 40 microns in diameter with a m esh opening of 37 microns and 23% open area.
7. A disposable filter element in accordance with claim 1, in which the filaments are heat set to lock them in place.
8. A disposable filter unit comprising a filter element according to claim 1 and a housing having an inlet and an outlet and line connections thereat for fluid flow into and out from the housing, the filter element being disposed in the housing across the line of flow therebetween so that fluid flow therebetween must pass through the filter element.
9. A disposable filter unit in accordance with claim 8, in which one line connection has a direct fluid flow connection to the interior of the filter cylinder.
10. A disposable filter unit in accordance with claim 8, in which the housing has an air vent closed off by a removable cap.
11. A disposable filter unit in accordance with claim 10, in which the cap closes off the vent in a tapered seal, the vent having a tapered bore, and the cap a tapered member projecting into and seating in the bore.
12. A disposable filter unit in accordance with claim 8, having a housing made in two portions bonded together .
13. A disposable filter unit in accordance with claim 12, made of plastic, with the portions fused together into one piece.
14. A disposable filter unit in accordance with claim 13, 38037/2 including line connections integral with the housing.
15. A disposable filter unit in accordance with claim 13, having the filter unit bonded to one housing portion.
16. A disposable filter unit in accordance with claim 15, having the filter unit bonded to one housing portion at the outlet with a direct fluid flow line connection from the filtrate -flow side of the filter element to the outlet.
17. A disposable filter unit in accordance with claim 8, having an air vent closed off by a removable cap, and a barrier at the inlet and attached to the housing in a position to shield the air vent from inlet flow .
18. A disposable filter in which the barrier and air vent ar 19
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8835670A | 1970-11-10 | 1970-11-10 | |
| CH1144371 | 1971-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL38087A true IL38087A (en) | 1974-11-29 |
Family
ID=25708347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL3808771A IL38087A (en) | 1970-11-10 | 1971-11-07 | Preparation of n-(diethylaminoethyl)-2-methoxy-4-afilter for use in the filtration of blood mino-5-chloro-benzamide |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL38087A (en) |
-
1971
- 1971-11-07 IL IL3808771A patent/IL38087A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3701433A (en) | Filter for use in the filtration of blood | |
| US3765536A (en) | Blood filter cascade | |
| US3765537A (en) | Dual blood filter | |
| CA1117032A (en) | Blood filter | |
| US4911846A (en) | Fluid treating apparatus and method of using it | |
| US4073732A (en) | Media for filtering blood | |
| US4743371A (en) | Blood filter | |
| JP5152985B2 (en) | Blood processing filter device and blood processing method | |
| US5258127A (en) | Leucocyte depleting filter device and method of use | |
| EP0910451B1 (en) | Biological fluid filter device comprising a leukocyte depletion medium | |
| US5540841A (en) | Cardioplegia filter and method for processing cardioplegia fluid | |
| US4450078A (en) | Microfiltration device for the filtration of coagula and microaggregates from blood | |
| EP0315022B1 (en) | Filtering device for blood platelet | |
| US7655146B2 (en) | Method for filtering blood or blood components using leukocyte-removing filter and filter device | |
| WO2006126497A1 (en) | Body fluid treating filter device | |
| KR20050084078A (en) | Method of removing leukocytes, leukocyte-removing filter and utilization thereof | |
| EP0909188A1 (en) | Blood treatment system | |
| JP2004130085A (en) | Selective leukocyte removal unit for platelet products | |
| PT953361E (en) | Fitration bag and filtration bag set | |
| JPH059112B2 (en) | ||
| JPH04240456A (en) | Filter apparatus for removing leukocyte and method for using it | |
| EP0604590B1 (en) | Gas plasma treated porous medium and method of separation using same | |
| JP5631731B2 (en) | Blood treatment filter | |
| FI59724B (en) | DUALFILTER ANVAENDBART VID BLODTRANSFUSIONER | |
| IL38087A (en) | Preparation of n-(diethylaminoethyl)-2-methoxy-4-afilter for use in the filtration of blood mino-5-chloro-benzamide |